DISPUTE SETTLEMENT
DS: European Communities — Patent Protection for Pharmaceutical and Agricultural Chemical Products
This summary has been prepared by the Secretariat under its own responsibility. The summary is for general information only and is not intended to affect the rights and obligations of Members.
See also:
Current status
back to top
Key facts
back to top
Latest document
back to top
Summary of the dispute to date
The summary below was up-to-date at
Consultations
Complaint by Canada.
On 2 December 1998, Canada requested consultations with the EC in respect of the protection of inventions in the area of pharmaceutical and agricultural chemical products under the relevant provisions of EC legislation, particularly Council Regulation (EEC) No. 1768/92 and European Parliament and Council Regulation (EC) No. 1610/96, in relation to EC obligations under the TRIPS Agreement. Canada considered that under the above Regulations, a patent term extension scheme, which is limited to pharmaceutical and agricultural chemical products, has been implemented. Canada alleged that Regulations (EEC) No. 1768/92 and (EC) No. 1610/96 are inconsistent with the EC’s obligations not to discriminate on the basis of field of technology, as provided by Article 27.1 of the TRIPS Agreement, because these Regulations only apply to pharmaceutical and agricultural products.
Share
Follow this dispute
Problems viewing this page? If so, please contact [email protected] giving details of the operating system and web browser you are using.